z-logo
open-access-imgOpen Access
Discovery of an alternative pathway of peptidoglycan biosynthesis: A new target for pathway specific inhibitors
Author(s) -
Yasushi Ogasawara,
Tohru Dairi
Publication year - 2021
Publication title -
journal of industrial microbiology and biotechnology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.857
H-Index - 112
eISSN - 1476-5535
pISSN - 1367-5435
DOI - 10.1093/jimb/kuab038
Subject(s) - peptidoglycan , biology , xanthomonas , bacterial cell structure , metabolic pathway , xanthomonas campestris , biosynthesis , microbiology and biotechnology , alternative complement pathway , biochemistry , cell wall , enzyme , bacteria , gene , genetics , antibody , complement system
Peptidoglycan in bacterial cell walls is a biopolymer consisting of sugars and amino acids and plays important role in maintaining cell integrity from the environment. Its biosynthesis is a major target for antibiotics and the genes and enzymes involved in the biosynthetic pathway have been well studied. However, we recently identified an alternative pathway in the early stage of peptidoglycan biosynthesis in Xanthomonas oryzae, a plant pathogen causing bacterial blight disease of rice. The distribution of the alternative pathway is limited to relatively few bacterial genera that contain many pathogenic species, including Xylella and Stenotrophomonas, besides Xanthomonas. Thus, the alternative pathway is an attractive target for the development of narrow-spectrum antibiotics specific to pathogens. In this minireview, we summarize the discovery of the alternative pathway and identification of its specific inhibitors.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom